276 related articles for article (PubMed ID: 19810131)
1. Risk index score for bacteremia in febrile neutropenic episodes in children with malignancies.
Spasova MI; Grudeva-Popova JG; Kostyanev SS; Genev ED; Stoyanova AA; Kirina VI; Moumdjiev IN
J BUON; 2009; 14(3):411-8. PubMed ID: 19810131
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
3. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
4. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
5. Significance of C-reactive protein during febrile neutropenia in pediatric malignancies.
Avabratha KS; Rau AT; Venkataravanamma P; Rau A
Indian Pediatr; 2009 Sep; 46(9):797-9. PubMed ID: 19430077
[TBL] [Abstract][Full Text] [Related]
6. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation.
Castagnola E; Fontana V; Caviglia I; Caruso S; Faraci M; Fioredda F; Garrè ML; Moroni C; Conte M; Losurdo G; Scuderi F; Bandettini R; Tomà P; Viscoli C; Haupt R
Clin Infect Dis; 2007 Nov; 45(10):1296-304. PubMed ID: 17968824
[TBL] [Abstract][Full Text] [Related]
7. [Bacteremia in children with tumors or malignant diseases 1991-2000].
Alfredsdóttir IH; Thors VS; Gudnason T; Jónmundsson G; Kristinsson JR; Jónsson OG; Kristinsson KG; Haraldsson A
Laeknabladid; 2008 Jul; 94(7-8):531-9. PubMed ID: 18591728
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia.
Latiff Z; Zulkifli SZ; Jamal R
Malays J Pathol; 2002 Dec; 24(2):83-9. PubMed ID: 12887165
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
[TBL] [Abstract][Full Text] [Related]
10. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.
McMeekin DS; Gazzaniga C; Berman M; DiSaia P; Manetta A
Gynecol Oncol; 1996 Aug; 62(2):247-53. PubMed ID: 8751557
[TBL] [Abstract][Full Text] [Related]
11. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
12. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
[TBL] [Abstract][Full Text] [Related]
13. [Criteria of low risk of mortality in children with neutropenia and fever during cancer chemotherapy].
Paganini HR; Rodríguez Brieshcke T; Zubizarreta P; Latella A; Firpo V; Fernandez C; Armada A; Casimir L; Debbag R
Medicina (B Aires); 2001; 61(1):63-6. PubMed ID: 11265626
[TBL] [Abstract][Full Text] [Related]
14. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
[TBL] [Abstract][Full Text] [Related]
15. Prospective audit of treatment of paediatric febrile neutropenia in Australasia.
Chamberlain JD; Smibert E; Skeen J; Alvaro F
J Paediatr Child Health; 2005 Nov; 41(11):598-603. PubMed ID: 16398846
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients.
Schlapbach LJ; Aebi C; Otth M; Leibundgut K; Hirt A; Ammann RA
Pediatr Infect Dis J; 2007 Nov; 26(11):989-94. PubMed ID: 17984804
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
Oude Nijhuis C; Kamps WA; Daenen SM; Gietema JA; van der Graaf WT; Groen HJ; Vellenga E; Ten Vergert EM; Vermeulen KM; de Vries-Hospers HG; de Bont ES
J Clin Oncol; 2005 Oct; 23(30):7437-44. PubMed ID: 16234511
[TBL] [Abstract][Full Text] [Related]
19. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Pediatr Infect Dis J; 2004 Jan; 23(1):61-7. PubMed ID: 14743049
[TBL] [Abstract][Full Text] [Related]
20. Risk prediction of fever in neutropenia in children with cancer: a step towards individually tailored supportive therapy?
Wicki S; Keisker A; Aebi C; Leibundgut K; Hirt A; Ammann RA
Pediatr Blood Cancer; 2008 Dec; 51(6):778-83. PubMed ID: 18726920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]